Xalkori

Pfizer Laboratories Div Pfizer Inc🇺🇸 United States

FDA Page

Effective Date: Nov 20, 2023
Approval ID: 2a51b0de-47d6-455e-a94c-d2c737b04ff7
Products: 5 registered
Version: 43

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use XALKORI safely and effectively. See full prescribing information for XALKORI. XALKORI (crizotinib) capsules, for oral useXALKORI (crizotinib) oral pelletsInitial U.S. Approval: 2011

Quick Stats

Total Products5

Labelers2

Label Sections23

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.